CA3105993A1 - Dysosmobacter, nouveau genre bacterien du microbiote gastro-intestinal et ses utilisations - Google Patents

Dysosmobacter, nouveau genre bacterien du microbiote gastro-intestinal et ses utilisations Download PDF

Info

Publication number
CA3105993A1
CA3105993A1 CA3105993A CA3105993A CA3105993A1 CA 3105993 A1 CA3105993 A1 CA 3105993A1 CA 3105993 A CA3105993 A CA 3105993A CA 3105993 A CA3105993 A CA 3105993A CA 3105993 A1 CA3105993 A1 CA 3105993A1
Authority
CA
Canada
Prior art keywords
bacterium
composition
variant
cells
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3105993A
Other languages
English (en)
Inventor
Patrice Cani
Tiphaine LE ROY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Catholique de Louvain UCL
Original Assignee
Universite Catholique de Louvain UCL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Catholique de Louvain UCL filed Critical Universite Catholique de Louvain UCL
Publication of CA3105993A1 publication Critical patent/CA3105993A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne une bactérie appartenant à un nouveau genre bactérien, Dysosmobacter, et son utilisation thérapeutique, nutraceutique et cosmétique.
CA3105993A 2018-07-10 2019-07-10 Dysosmobacter, nouveau genre bacterien du microbiote gastro-intestinal et ses utilisations Pending CA3105993A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18305916.1A EP3594321A1 (fr) 2018-07-10 2018-07-10 Dusodibacter, nouveau genre bactérien du microbiote gastro-intestinal et ses utilisations
EP18305916.1 2018-07-10
PCT/EP2019/068539 WO2020011856A1 (fr) 2018-07-10 2019-07-10 Dysosmobacter, nouveau genre bactérien du microbiote gastro-intestinal et ses utilisations

Publications (1)

Publication Number Publication Date
CA3105993A1 true CA3105993A1 (fr) 2020-01-16

Family

ID=63041945

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3105993A Pending CA3105993A1 (fr) 2018-07-10 2019-07-10 Dysosmobacter, nouveau genre bacterien du microbiote gastro-intestinal et ses utilisations

Country Status (6)

Country Link
US (2) US11690879B2 (fr)
EP (2) EP3594321A1 (fr)
JP (1) JP7487948B2 (fr)
CN (1) CN113286872B (fr)
CA (1) CA3105993A1 (fr)
WO (1) WO2020011856A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112680500A (zh) * 2020-12-30 2021-04-20 深圳市第二人民医院(深圳市转化医学研究院) 一种用于1型糖尿病检测的试剂、生物标志物及其应用
CN113832128A (zh) * 2021-09-27 2021-12-24 西南医科大学 一种新的糖苷酶及其制备方法与应用
WO2024028479A1 (fr) 2022-08-05 2024-02-08 Universite Catholique De Louvain Dysosmobacter pour le traitement du cancer du sein
CN116144561B (zh) * 2022-10-08 2024-02-27 华东理工大学 一种降解n,n-二甲基甲酰胺的大肠杆菌工程菌及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008076696A2 (fr) 2006-12-18 2008-06-26 Washington University In St. Louis Microbiome intestinal en tant que biomarqueur et cible thérapeutique pour traiter l'obésité ou un trouble lié à l'obésité
EP2030623A1 (fr) 2007-08-17 2009-03-04 Nestec S.A. Prévention et/ou traitement de troubles métaboliques par la modulation de la quantité d'entérobactéries
WO2014075745A1 (fr) * 2012-11-19 2014-05-22 Université Catholique de Louvain Utilisation d'akkermansia pour le traitement de troubles métaboliques
EP2951285A4 (fr) * 2013-02-04 2016-10-26 Seres Therapeutics Inc Compositions et procédés pour l'inhibition de croissance bactérienne pathogène
GB2551642B (en) * 2014-10-31 2020-09-23 Pendulum Therapeutics Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
US11786562B2 (en) * 2016-04-19 2023-10-17 Genome Research Limited Bacteriotherapy

Also Published As

Publication number Publication date
US20210338745A1 (en) 2021-11-04
JP2021531748A (ja) 2021-11-25
CN113286872B (zh) 2024-03-22
EP3594321A1 (fr) 2020-01-15
US11690879B2 (en) 2023-07-04
JP7487948B2 (ja) 2024-05-21
US20230372412A1 (en) 2023-11-23
EP3820990A1 (fr) 2021-05-19
WO2020011856A1 (fr) 2020-01-16
CN113286872A (zh) 2021-08-20

Similar Documents

Publication Publication Date Title
US11690879B2 (en) Dysosmobacter, a novel bacterial genus of the gastrointestinal microbiota and uses thereof
US10653730B2 (en) Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
JP7012377B2 (ja) 新規な細菌種
US8309076B2 (en) Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation
JP6357222B2 (ja) 酪酸産生菌及びその利用
KR101279852B1 (ko) 골다공증 예방 또는 치료용 조성물
Todorov et al. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain
Li et al. Protective effects of a novel Lactobacillus rhamnosus strain with probiotic characteristics against lipopolysaccharide-induced intestinal inflammation in vitro and in vivo
Zhai et al. Screening of Lactobacillus salivarius strains from the feces of Chinese populations and the evaluation of their effects against intestinal inflammation in mice
US20200237837A1 (en) Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
CN117384790B (zh) 一株戊糖片球菌ks5及其在制备助睡眠药品中的应用
Priya In Vitro Evaluation of Probiotic, Antimicrobial, and Antioxidant Properties of a Novel Lactobacillus plantarum Strain Isolated from Medicago sativa
Vijayakumar Mayakrishnan et al. In vitro evaluation of probiotic, antimicrobial, and antioxidant properties of a novel Lactobacillus plantarum strain isolated from medicago sativa.
WO2024028479A1 (fr) Dysosmobacter pour le traitement du cancer du sein
EA044429B1 (ru) Штамм akkermansia glycaniphilus, композиция, содержащая штамм, применение штамма и композиции, способ повышения уровня штамма akkermansia glycaniphilus в желудочно-кишечном тракте
Slattery et al. Analysis of Health Benefits Conferred by Species from Kefir.